Welcome to our dedicated page for Nugene Intl SEC filings (Ticker: NUGN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
nugene international, inc. develops and markets customized skin care products in the united states. the company offers skincare products, such as universal cream, universal and eye serum, gel, and face wash products; and hair care products comprising regenerative shampoos and conditioners, and anti-hair loss serums. it is also involved in the research and formulation of a topical burn cream for the treatment of burns. the company offers its products to wholesale distributors, physicians, and consumers. nugene international, inc. is based in irvine, california.A holder of the issuer’s common stock has filed a notice of proposed sale under Rule 144 to sell 100,000,000 common shares through Fidelity Investments on the OTC Markets, with an approximate sale date of 01/14/2026 and an aggregate market value listed as $1,900,000,000. The table states that 120,207,050 shares of this class are outstanding.
The securities to be sold were acquired as a purchase from Livento Group dated 09/28/2023, with an amount of 100,000,000 shares and payment by wire on 09/18/2023. The signer represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.
Livento Group, Inc. (NUGN) reported it issued 1,000,000,000 common shares to its Chief Investment Officer, Michael Gregory Max Henriksen, on August 26, 2025. The shares were priced at $0.001 per share for a total purchase price of $1,000,000, pursuant to a Subscription Agreement dated August 19, 2025, which is included as Exhibit 1.0.
The filing is presented under Item 5.02 and notes the company’s common stock trades on OTC Pink under the symbol NUGN.
Livento Group (NUGN) insider Michael Gregory Max Henriksen reported a purchase of 2,000,000,000 common shares at $0.002 per share on 10/22/2025 (transaction code P).
Following the transaction, he directly beneficially owned 3,083,040,806 shares. The filing lists his role as Chief Investment Officer and was filed by one reporting person.
Livento Group (NUGN) reported an initial statement of beneficial ownership on Form 3 for Michael Gregory Max Henriksen. He is listed as an officer (Chief Investment Officer) and a 10% Owner.
The filing reports beneficial ownership of 3,083,040,806 shares of Common Stock and 250,000,000 shares of Series C Convertible Preferred Stock, each shown as Direct (D) ownership. The event date is 10/22/2025.
Livento Group, Inc. (NUGN) filed its Q3 2025 10‑Q, reporting quarterly revenues of $329,423 and a net loss of $225,085. Cost of revenues, led by amortization and professional fees, totaled $771,921, resulting in a gross loss of $442,498. Other income contributed $355,627 in the quarter.
For the nine months ended September 30, 2025, the company posted revenues of $876,211, other income of $891,227, and a net loss of $755,294. Management attributes performance to its AI software platform Elisee and a shift toward movie projects under BOXO, with movie-related inflows reflected in other income.
On the balance sheet, total assets were $44.5 million, including $42.7 million net fixed assets driven by intangible assets. Total liabilities were $2.8 million, and accumulated deficit stood at $21.1 million. Common shares outstanding were 2,279,753,594 as of September 30, 2025. The company reported no active legal proceedings.
FAQ
What is the current stock price of Nugene Intl (NUGN)?
What is the market cap of Nugene Intl (NUGN)?
